Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa

NCT03977818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2165

Last updated 2025-09-05

Study results available
· View outcomes & findings →

Summary

Well-designed observational studies of individuals with rare tumors are needed to improve patient care, clinical investigations, and the education of healthcare professionals.

The patterns of care, outcomes, and prognostic factors of a cohort of 2225 patients with metastatic soft tissue sarcomas who were diagnosed between 1990 and 2013 and documented in the prospectively maintained database of the French Sarcoma Group will be analyzed with a focus on : number/frequency of systemic treatments per patient, number/frequency of patients with locoregional treatment of the metastasis, number/frequency of patients with chemotherapy, number/frequency of patients with an off-label drug.

Outcome (time-to-next treatment \[TNT\] and overall survival \[OS\]) will be reported according to histological subtype, as well as the association between TNT and OS.

Prognostic factors of OS will be investigated.

Conditions

Sponsors & Collaborators

  • French Sarcoma Group

    collaborator OTHER
  • Institut Bergonié

    lead OTHER

Principal Investigators

  • Antoine Italiano, MD/PhD · Institut Bergonié, Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-01-01
Primary Completion
2017-01-01
Completion
2017-01-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03977818 on ClinicalTrials.gov